Analysts expect Beyondspring Inc (NASDAQ:BYSI) to announce earnings of ($0.55) per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Beyondspring’s earnings. Beyondspring posted earnings of ($0.68) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 19.1%. The business is scheduled to report its next earnings results on Tuesday, April 2nd.
According to Zacks, analysts expect that Beyondspring will report full year earnings of ($2.25) per share for the current financial year. For the next financial year, analysts forecast that the firm will report earnings of ($2.02) per share. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Beyondspring.
Beyondspring (NASDAQ:BYSI) last released its earnings results on Tuesday, October 23rd. The company reported ($0.54) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.62) by $0.08.
A number of research firms have issued reports on BYSI. Zacks Investment Research raised Beyondspring from a “hold” rating to a “buy” rating and set a $21.00 target price for the company in a research report on Friday, October 26th. HC Wainwright set a $60.00 target price on Beyondspring and gave the stock a “buy” rating in a research report on Thursday. Finally, Maxim Group reissued a “buy” rating and issued a $35.00 target price (down from $48.00) on shares of Beyondspring in a research report on Thursday, October 25th.
An institutional investor recently raised its position in Beyondspring stock. Tanaka Capital Management Inc. boosted its position in Beyondspring Inc (NASDAQ:BYSI) by 106.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 49,584 shares of the company’s stock after buying an additional 25,606 shares during the quarter. Beyondspring makes up about 2.9% of Tanaka Capital Management Inc.’s holdings, making the stock its 11th largest position. Tanaka Capital Management Inc. owned about 0.22% of Beyondspring worth $1,240,000 at the end of the most recent reporting period. 1.37% of the stock is owned by institutional investors.
NASDAQ:BYSI traded up $0.52 during trading hours on Friday, reaching $24.11. The stock had a trading volume of 16,826 shares, compared to its average volume of 9,101. Beyondspring has a 12-month low of $16.15 and a 12-month high of $34.00. The company has a market capitalization of $529.26 million, a P/E ratio of -5.48 and a beta of 1.33.
Beyondspring Company Profile
BeyondSpring Inc, a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. The company is advancing its lead asset, Plinabulin, into a Phase 2/3 clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase 2/3 clinical trial for the prevention of non-docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase 3 clinical trial as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer; and Phase 1/2 clinical trials with the immuno-oncology agent nivolumab.
Read More: Quiet Period
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Beyondspring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyondspring and related companies with MarketBeat.com's FREE daily email newsletter.